The latest closing stock price for Kymera Therapeutics as of January 21, 2025 is 43.70.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $314 today, roughly 0 times their original investment - a 7.06% compound annual growth rate over 4 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 21.9% above the current share price.
The Kymera Therapeutics 52-week low stock price is 29.24, which is 33.1% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 40.82.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $314 today, roughly 0 times their original investment - a 7.06% compound annual growth rate over 4 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 21.9% above the current share price.
The Kymera Therapeutics 52-week low stock price is 29.24, which is 33.1% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 40.82.